ESSA Pharma Inc. (EPIX)
ESSA Pharma Statistics
Share Statistics
ESSA Pharma has 44.39M shares outstanding. The number of shares has increased by 0.06% in one year.
| Shares Outstanding | 44.39M |
| Shares Change (YoY) | 0.06% |
| Shares Change (QoQ) | 0.04% |
| Owned by Institutions (%) | 74.21% |
| Shares Floating | 41.72M |
| Failed to Deliver (FTD) Shares | 5.15K |
| FTD / Avg. Volume | 3% |
Short Selling Information
The latest short interest is 691.47K, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 691.47K |
| Short % of Shares Out | 1.56% |
| Short % of Float | 1.59% |
| Short Ratio (days to cover) | 0.32 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -3.96. ESSA Pharma's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -3.96 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 2.09 |
| P/FCF Ratio | -11.81 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ESSA Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 38.64, with a Debt / Equity ratio of 0.
| Current Ratio | 38.64 |
| Quick Ratio | 38.64 |
| Debt / Equity | 0 |
| Debt / EBITDA | - |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $0 |
| Employee Count | 35 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -82.34% in the last 52 weeks. The beta is 1.61, so ESSA Pharma's price volatility has been higher than the market average.
| Beta | 1.61 |
| 52-Week Price Change | -82.34% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 3.51 |
| Relative Strength Index (RSI) | 29.11 |
| Average Volume (20 Days) | 171.59K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | 0 |
| Net Income | 0 |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.64 |
Balance Sheet
The company has 103.71M in cash and 329.26K in debt, giving a net cash position of 103.38M.
| Cash & Cash Equivalents | 103.71M |
| Total Debt | 329.26K |
| Net Cash | 103.38M |
| Retained Earnings | 0 |
| Total Assets | 122.63M |
| Working Capital | 118.42M |
Cash Flow
In the last 12 months, operating cash flow was -22.72M and capital expenditures 0, giving a free cash flow of -22.72M.
| Operating Cash Flow | -22.72M |
| Capital Expenditures | 0 |
| Free Cash Flow | -22.72M |
| FCF Per Share | -0.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EPIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for EPIX is $2, which is 35.1% higher than the current price. The consensus rating is "Hold".
| Price Target | $2 |
| Price Target Difference | 35.1% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Apr 25, 2018. It was a backward split with a ratio of 1:20.
| Last Split Date | Apr 25, 2018 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | 8.7 |
| Piotroski F-Score | 1 |